Quantify any protein, in any sample, with any modification, without antibodies
Target Sufficiency® enables direct, quantitative analysis of drug target systems in cells, biofluids, tissues, and tissue models, including formalin-fixed, paraffin-embedded (FFPE) tissues.
Inotiv provides the broadest range of research models and related services to pharmaceutical and biotech companies, government, academia, and other life science organizations.
September 8-11, 2024 Copenhagen, Denmark Booth #15 EUROTOX is the Federation of European Toxicologists and European Societies of Toxicology, which tog...
September 11, 2024 11 am—12 pm Online webinar Protect your research with robust rodent health monitoring. Ensuring the health and well-being of your rodent research colony...
September 15-18, 2024 Honolulu, HI Booth #108 This co-organized meeting for JSSX and ISSX with a focus on The Future of Translational Xenobiotic Resea...
Due to the current FDA concern and guidance on reducing the risk of Nitrosamine impurities in human drugs, there has been an increased industry need for testing of these impurities using the Bacterial Reverse Mutation (Ames) test. As Nitrosamines are not readily detectable by standard Ames methodologies, specifically cited in the Ames testing guideline (OECD 471), the need for a robust protocol better suited for this class of compounds is warranted.
General Toxicology
Histology
Pathology
DMPK
Consulting
Research Models
Research Model Services
Teklad Diet and Bedding
